Condition: Type1diabetes · Diabetes · Sponsor: Second Xiangya Hospital of Central South University
The aim of the China Diabetes Type 1 Study (CD1S) is to conduct a nationwide type 1 diabetes (T1D) registry study in patients with T1D and in pediatric adolescent patients with diabetes who had an age of onset \<= 20 years. CD1S compromises a retrospective study enrolling inpatients hospitalized from Jan 1st, 2016 to Dec 31, 2021, and a prospective study beginning from the year 2022.
This description comes directly from the study's public registry record.
Zhiguang Zhou, MD, PhD · +8673185292154 · zhouzhiguang@csu.edu.cn
Xia Li, MD, PhD · lixia@csu.edu.cn
Always discuss trial participation with your own doctor first.
| Gansu Provincial People's Hospital | Lanzhou, Gansu, China | Recruiting |
| Shenzhen Second People's Hospital | Shenzhen, Guangdong, China | Recruiting |
| Hainan General Hospital | Haikou, Hainan, China | Recruiting |
| the First Affiliated Hospital of Harbin Medical University | Harbin, Heilongjiang, China | Recruiting |
| The First Affiliated Hospital of Henan University of Science and Technology | Luoyang, Henan, China | Recruiting |
| The Second Xiangya Hospital, Central South University | Changsha, Hunan, China | Recruiting |
| The First Affiliated Hospital of Nanjing Medical University | Nanjing, Jiangsu, China | Not Yet Recruiting |
| Heji Hospital Affiliated to Changzhi Medical College | Changzhi, Shanxi, China | Recruiting |
| The First Affiliated Hospital of Xinjiang Medical University | Ürümqi, Xinjiang, China | Recruiting |
| The First People's Hospital of Yunnan | Kunming, Yunnan, China | Recruiting |
| Zhejiang Provincial People's Hospital | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05498974